Trial Profile
A Double-Blind, Multicenter, Placebo-Controlled Study of MK0777 Gel Extrusion Module (GEM) 1.5 mg b.i.d. in the Treatment of Outpatients With Generalized Anxiety Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs MK 0777 (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 24 Dec 2014 New trial record